On November 16, 2018, the nodes of the moon will shift into the signs of Cancer/Capricorn, and out of Leo/Aquarius. (True node changes signs on November 7). In this video, we discuss this from the perspective of collective karma and the evolutionary tasks that humanity has to face from 2018 to 2020.
We have so much going on in November 2018: Mars, Jupiter, Uranus and the nodal axis all change signs, and Venus, Neptune and Mercury change directions. In this video, we unpack the astrology of the first half of the month – examining its personal and collective implications.
From October 5 to November 15, Venus is retrograde, spanning the relational signs of Scorpio and Libra. From October 5 to 31, Venus is retrograde in the sign of Scorpio, and from November 1 to 15, Venus is retrograde in Libra.
In this video, we examine the personal and collective significance of this transit, unpacking the evolutionary imperatives of Venus in Scorpio and Venus in Libra. We also unpack the important aspects and events happening within this retrograde window: the Libra new moon, Venus opposing Uranus and Venus sextile Saturn.
In this video I look at the astrology of August – from the 1st to the 15th of the month. We discuss the major transits: the Mars/Uranus square, Uranus going retrograde until January 2019, the Sun and Mercury squaring up with Jupiter in Scorpio, Venus changing signs and aspecting Mars, Saturn and Chiron, the new moon solar eclipse happening on August 11, and retrograde Mars dipping back into Capricorn. As usual, we look at the personal psychological significance of these transits, as well as their collective implications.
A portrait of the “double-edged” sword that Neptune retrograde in Pisces is. Neptune will be retrograde from June to November, 2018. We look at how to psychically cope within Neptune’s retrograde period, contextualizing it along with Saturn and Pluto retrograde in Capricorn.
An account of Saturn and Pluto retrograde, in the context of other major transits. Key themes and lessons for the collective.